Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2010; 16(45): 5727-5731
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5727
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5727
Table 2 Genotype frequencies of SLC11A1 1730G>A (rs17235409) in inflammatory bowel disease patients who have used/not used immunomodulators n (%)
| Phenotype/immunomodulator status | Genotype | P value | OR (95% CI) | ||
| GG | GA | AA | |||
| CD/never used IM (n = 217) | 203 (94) | 14 (6) | 0 | 0.031 | 0.38 (0.15-0.95) |
| CD/have used IM (n = 278) | 271 (98) | 7 (2) | 0 | ||
| UC/never used IM (n = 356) | 336 (94) | 20 (6) | 0 | 0.010 | 0.75 (0.71-0.79) |
| UC/have used IM (n = 114) | 114 (100) | 0 | 0 | ||
| IBD/never used IM (n = 573) | 539 (94) | 34 (6) | 0 | 0.002 | 0.29 (0.13-0.66) |
| IBD/have used IM (n = 392) | 385 (98) | 7 (2) | 0 | ||
-
Citation: Stewart LC, Day AS, Pearson J, Barclay ML, Gearry RB, Roberts RL, Bentley RW.
SLC11A1 polymorphisms in inflammatory bowel disease andMycobacterium avium subspeciesparatuberculosis status. World J Gastroenterol 2010; 16(45): 5727-5731 - URL: https://www.wjgnet.com/1007-9327/full/v16/i45/5727.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i45.5727